Joost van der Mark
Corporate Officer/Principal chez BIOSYENT INC.
Fortune : 338 263 $ au 31/03/2024
Profil
Joost van der Mark is the founder of Orphan Canada, Inc. He is currently the Vice President-Corporate Development at BioSyent, Inc. He has previously worked as Vice President-Corporate Development at BioSyent, Inc. from 2015 to 2017 and as Chief Business Officer at Telo Genomics Corp.
from 2017 to 2018.
He also worked as Vice President-Corporate Development at Knight Therapeutics, Inc. Mr. van der Mark holds an MBA from York University and The Schulich School of Business, and a graduate degree from the University of Western Ontario.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
BIOSYENT INC.
0,45% | 27/03/2024 | 52 730 ( 0,45% ) | 338 263 $ | 31/03/2024 |
Postes actifs de Joost van der Mark
| Sociétés | Poste | Début |
|---|---|---|
| BIOSYENT INC. | Corporate Officer/Principal | 10/09/2018 |
Anciens postes connus de Joost van der Mark
| Sociétés | Poste | Fin |
|---|---|---|
| TELO GENOMICS CORP. | Corporate Officer/Principal | 31/05/2018 |
| BIOSYENT INC. | Corporate Officer/Principal | 01/01/2017 |
| KNIGHT THERAPEUTICS INC. | Corporate Officer/Principal | - |
Orphan Canada, Inc.
 Orphan Canada, Inc. Pharmaceuticals: MajorHealth Technology Part of Knight Therapeutics, Inc., Orphan Canada, Inc. is a Canadian company that manufactures specialty pharmaceuticals. The private company was founded by Jason Flowerday, Joost van der Mark. Orphan Canada was acquired by Knight Therapeutics, Inc. on September 02, 2014. | Founder | - |
Formation de Joost van der Mark
| York University | Masters Business Admin |
| University of Western Ontario | Graduate Degree |
| The Schulich School of Business | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| KNIGHT THERAPEUTICS INC. | Health Technology |
| TELO GENOMICS CORP. | Health Services |
| Entreprise privées | 2 |
|---|---|
| BioSyent, Inc. | |
Orphan Canada, Inc.
Orphan Canada, Inc. Pharmaceuticals: MajorHealth Technology Part of Knight Therapeutics, Inc., Orphan Canada, Inc. is a Canadian company that manufactures specialty pharmaceuticals. The private company was founded by Jason Flowerday, Joost van der Mark. Orphan Canada was acquired by Knight Therapeutics, Inc. on September 02, 2014. | Health Technology |
